Table 2. Clinical evaluation of KTT, KTH, CAL, RC.
Variable | Test group-1 (n=21) | Test group-2 (n=21) | Control group (n=21) | ||||
---|---|---|---|---|---|---|---|
Mean±SD | Median | Mean±SD | Median | Mean±SD | Median | p | |
KTT | |||||||
Baseline | 1.75±0.35 | 1.73 | 1.60±0.34 | 1.52 | 1.61±0.49 | 1.62 | 0.305 |
3 months | 1.98±0.45 | 1.87 | 1.81±0.41 | 1.73 | 2.39±0.42 | 2.43 | 0.0001* |
6 months | 1.86±0.49 | 1.75 | 1.78±0.42 | 1.62 | 2.35±1.02 | 2.47 | 0.0001* |
KTH | |||||||
Baseline | 4.43±1.21 | 4 | 3.95±1.02 | 4 | 3.05±0.86 | 3 | 0.001* |
1 month | 4.43±1.08 | 4 | 4.00±1.14 | 4 | 4.19±0.93 | 4 | 0.342 |
3 months | 4.62±0.92 | 4 | 3.90±1.09 | 4 | 5.05±1.02 | 5 | 0.005* |
6 months | 4.86±0.96 | 5 | 4.14±1.24 | 4 | 5.29±1.01 | 5 | 0.006* |
CAL | |||||||
Baseline | 4.10±1.03 | 4 | 3.86±0.69 | 4 | 3.88±0.80 | 4 | 0.807 |
3 months | 2.52±0.66 | 2.5 | 2.21±0.68 | 2.5 | 2.02±0.84 | 1.5 | 0.081 |
6 months | 2.86±0.74 | 3 | 1.93±0.69 | 2 | 1.57±0.71 | 1.5 | 0.0001* |
RC | |||||||
1 month | 65.57±11.94 | 66.6 | 63.07±13.12 | 60 | 68.02±20.39 | 66.6 | 0.786 |
3 months | 55.35±14.60 | 50 | 72.03±15.05 | 75 | 72.58±17.11 | 75 | 0.001* |
6 months | 56.34±14.51 | 50 | 69.65±15.28 | 75 | 80.13±18.93 | 83.3 | 0.0001* |
RW | |||||||
Baseline | 3.62±0.61 | 4 | 3.14±0.85 | 3 | 3.12±0.57 | 3 | 0.031* |
1 month | 2.86±0.65 | 3 | 1.40±0.49 | 1.5 | 1.38±0.97 | 1.5 | 0.0001* |
3 months | 2.60±0.68 | 2.5 | 1.29±0.41 | 1.5 | 1.19±0.68 | 1.5 | 0.0001* |
6 months | 2.64±0.59 | 3 | 1.24±0.58 | 1 | 1.02±0.81 | 1 | 0.0001* |